Iroko Pharmaceuticals announced that Zorvolex (diclofenac) capsules are now available. Zorvolex was approved in October 2013 for the treatment of mild-to-moderate acute pain in adults.

RELATED: Pain Management Resource Center

Zorvolex is an NSAID that exhibits anti-inflammatory, analgesic, and antipyretic activities in animal models. The mechanism of action of Zorvolex is not completely understood but may involve inhibition of the cyclooxygenase (COX-1 and COX-2) pathways. Its mechanism may also be related to prostaglandin synthetase inhibition.

Zorvolex is manufactured using SoluMatrix Fine Particle Technology, contains submicron particles of diclofenac that are about 20 times smaller than their original size.

Zorvolex is available in 18mg and 35mg dosage strength capsules in 30- and 90-count bottles.

For more information call (877) 757-0676 or visit